T-cells with self-reactive T-cell receptors are eliminated via the process of central and peripheral tolerance. Self-peptides are transported from different tissues in the body to the thymus, where they are presented to T-cells, which then receive pro-apoptotic signals. But how does the body know which peptides are self-peptides? Why aren't e.g. cancer neoantigens presented in the thymus as self-peptides? Is there a temporal component to it? 

More Martyna Sroka's questions See All
Similar questions and discussions